DV
Dividend Vision

CLPT Stock — Clearpoint Neuro Inc

Clearpoint Neuro Inc (CLPT)

Updated October 16, 2026.

CLPT is a Stock. Total return is 1109.3% over the past 14.4 years, 466.3 points ahead of SPY at 643.0%.

ClearPoint Neuro is a commercial-stage medical device company that develops and commercializes minimally invasive surgical platforms for brain procedures, including its ClearPoint systems (hardware, disposables, and software), Prism Neuro laser therapy system, and IRRAflow active fluid exchange platform. The company also provides consulting services to pharmaceutical and medical technology partners on testing, preclinical studies, and clinical trial support. The company does not currently distribute to shareholders.

CLPT dividend yield and income

Price as of 2026-10-16.

The payment date is 07/27/2016.

CLPT performance versus SPY

Price and return data through 2026-10-16.

Total return is 1109.3% over the past 14.4 years, 466.3 points ahead of SPY at 643.0%. Over the past year its total return — price change plus distributions reinvested — is -64.1%. Its deepest 1-year drawdown was 68.3%.

WindowTotal returnCAGR
1M-32.3%—
3M-39.8%—
6M-13.6%—
YTD-33.7%—
1Y-64.1%—
2Y CAGR—-13.00%
3Y CAGR—22.50%
5Y CAGR—-12.80%
10Y CAGR—5.50%
Since inception (14.4 years)1109.3%18.90%

CLPT key facts

Asset type
Stock
Asset class
Equity
Inception date
05/21/2012
Distribution frequency
None
Last close
$9.07 (as of 2026-10-16)
Market cap
$276,673,339
Average volume
965006.0
Payment date
07/27/2016
Beta
1.289
Payout ratio
0.0%
Forward P/E
12.1065
EPS
$-1.18

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

CLPT risks and drawbacks

The deepest 1-year drawdown on record here is 68.3%.

Who may consider CLPT — and who may not

It is a weaker fit for investors who need monthly cash flow (CLPT does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on CLPT

Tagged: Healthcare.

Frequently asked questions

Does CLPT pay monthly?

No. CLPT does not currently distribute.

When does CLPT pay a dividend?

CLPT does not currently distribute. The payment date is 07/27/2016.

How has CLPT performed?

Total return is 1109.3% over the past 14.4 years, 466.3 points ahead of SPY at 643.0%. Over the past year its total return — price change plus distributions reinvested — is -64.1%. Its deepest 1-year drawdown was 68.3%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.